167 results
8-K
BIOCQ
Biocept Inc
20 Oct 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
6:06am
on Form 8-K contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act
8-K
EX-99.1
BIOCQ
Biocept Inc
22 Aug 23
Biocept Reports Second Quarter 2023 Financial Results
4:10pm
of the Private Securities Litigation Reform Act of 1995. The reader is cautioned not to put undue reliance on these forward-looking statements
8-K
EX-99.1
kft 2ree3wimr
15 May 23
Biocept Reports First Quarter 2023 Financial Results
6:07am
DEFR14A
9ebi5mjgf4 j2y
21 Apr 23
Revised proxy
8:30am
8-K
EX-99.1
fxn0v0l
17 Apr 23
Biocept Reports 2022 Financial Results
4:46pm
8-K
1dq9f74xkljw 43
17 Apr 23
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
8:01am
8-K
EX-99.1
o51e2zi gio49pfdxj
21 Nov 22
Biocept Reports Third Quarter 2022 Financial Results
4:31pm
8-K
EX-99.1
3ajs 14qz5oqk5mkjt
14 Nov 22
Biocept Reports Second Quarter 2022 Financial Results
8:01am
8-K
EX-99.1
jk7f6lp y0xetw
14 Jul 22
Regulation FD Disclosure
6:07am
8-K
zsb9hi4dg ql
13 Jun 22
Other Events
4:06pm